4.6 Review

Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS

Steffen Halbgebauer et al.

Summary: The study showed that elevated levels of NfL and NfH in ALS patients compared to other neurological disorders. The correlation between CSF and serum NfL was stronger than that of NfH. CSF NfL had the best diagnostic potential for ALS, followed by CSF NfH, serum NfL, and serum NfH.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

Article Clinical Neurology

Biphasic cortical macro- and microstructural changes in autosomal dominant Alzheimer's disease

Victor Montal et al.

Summary: The study suggests a biphasic trajectory for brain structural changes in early preclinical Alzheimer's disease, with increases in cortical thickness and decreases in cortical diffusivity followed by cortical thinning and cortical diffusivity increases in later stages. The timing of these changes aligns with the start of tau biomarker alterations.

ALZHEIMERS & DEMENTIA (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

Future Imaging in Dementia

David J. Brooks

Summary: Imaging plays a crucial role in the diagnosis, disease tracking, and biomarker development of dementias. Future research will focus on standardized approaches, specific markers, and the effectiveness of neuroprotective treatments.

SEMINARS IN NUCLEAR MEDICINE (2021)

Article Clinical Neurology

TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis

Leon Beyer et al.

Summary: The study shows that measuring the misfolding of TDP-43 in the cerebrospinal fluid of ALS patients using immuno-infrared sensor technology has the potential to serve as a biomarker for ALS. The technology can accurately distinguish ALS patients from other control groups.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Article Neurosciences

Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology

Lucia A. A. Giannini et al.

Summary: Frontotemporal lobar degeneration proteinopathies with tau inclusions (FTLD-Tau) and TDP-43 inclusions (FTLD-TDP) show distinct severity and regional distribution of white matter and grey matter pathology, which may impact their clinical presentation.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Article Medicine, General & Internal

Diagnostic Utility of Measuring Cerebral Atrophy in the Behavioral Variant of Frontotemporal Dementia and Association With Clinical Deterioration

Ignacio Illan-Gala et al.

Summary: This study demonstrates that in bvFTD, VAS scores increase the diagnostic certainty of underlying FTLD, and the MRPI shows potential for detecting participants with underlying 4R tauopathies.

JAMA NETWORK OPEN (2021)

Article Neurosciences

Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid

Gustaf Bostrom et al.

Summary: The study revealed that levels of MMP-10 were elevated in AD, MCI/AD, and FTD patients, with additional proteins increased in MCI/AD. In contrast, FTD patients showed decreased levels of 36 proteins, while AD and MCI/AD patients did not show any decrease in protein levels. This suggests distinct patterns of neuroinflammatory processes in different neurodegenerative disorders.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Article Biochemistry & Molecular Biology

Lack of association between TREM2 rs75932628 variant and amyotrophic lateral sclerosis

Vasileios Siokas et al.

Summary: Studies on the role of the TREM2 rs75932628 variant in ALS have shown inconsistent results. However, meta-analyses combining data from various studies did not find a significant association between the rs75932628 variant and ALS risk. This suggests that TREM2 rs75932628 may not play a determining role in the pathophysiology of ALS.

MOLECULAR BIOLOGY REPORTS (2021)

Review Clinical Neurology

Non-neuronal cells in amyotrophic lateral sclerosis - from pathogenesis to biomarkers

Bjorn F. Vahsen et al.

Summary: The prevailing motor neuron-centric view of ALS pathogenesis may have hindered the identification of disease-modifying therapies. Evidence is accumulating for the involvement of non-neuronal cells, particularly microglia and astrocytes, in the pathophysiology of ALS.

NATURE REVIEWS NEUROLOGY (2021)

Review Clinical Neurology

Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it?

Fabiola De Marchi et al.

Summary: ALS is a progressive neurodegenerative disorder that not only affects motor neurons but also involves neuropsychological alterations. Detecting and monitoring cognitive and behavioral impairments in ALS patients at early stages is important for staging and prognosis. Research on biomarkers related to cognitive and behavioral alterations in ALS is still at an early stage, and more longitudinal studies are needed to clarify the relationship between biomarkers and cognitive decline.

NEUROLOGICAL SCIENCES (2021)

Article Clinical Neurology

Association of Cortical Hyperexcitability and Cognitive Impairment in Patients With Amyotrophic Lateral Sclerosis

Mana Higashihara et al.

Summary: This study found that cortical hyperexcitability was more pronounced in cognitively impaired patients with ALS, indicating a potential association between cognitive impairment and TDP-43 accumulation. Reduced SICI was evident in ALS patients, especially in those with decreased executive function scores.

NEUROLOGY (2021)

Article Clinical Neurology

Old age genetically confirmed frontotemporal lobar degeneration with TDP-43 has limbic predominant TDP-43 deposition

Marina Buciuc et al.

Summary: The burden of TDP-43 inclusions was assessed in elderly patients with genetic FTLD-TDP and compared to sporadic cases with TDP-43. It was found that patients with genetic FTLD-TDP had a higher burden in the entorhinal cortex compared to AD-TDP, but no significant difference in the middle frontal cortex burden.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2021)

Review Clinical Neurology

Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration

Stanley H. Appel et al.

Summary: In ALS, motor neuron cell death is initiated by multiple cell autonomous pathways leading to noncell autonomous inflammatory reactivity. This results in activated microglia, astrocytes, and pro-inflammatory innate and adaptive immune cells in patients. Dysregulation of cells and cytokines accurately reflect disease burdens, progression rates, and survival times in ALS, indicating potential therapeutic targets in systemic pro-inflammatory responses.

CURRENT OPINION IN NEUROLOGY (2021)

Review Neurosciences

Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis

Jessica Root et al.

Summary: Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are fatal neurodegenerative disorders linked by shared genetic causes, and lysosomal dysfunction is identified as an important pathological mechanism in both FTD and ALS, caused by genetic mutations or toxic-gain of function. Mutations in genes important for endosome-lysosome function are also found in other agedependent neurodegenerative diseases, indicating a potential commonality in lysosomal dysfunction across different diseases.

NEUROBIOLOGY OF DISEASE (2021)

Article Multidisciplinary Sciences

A multicentre validation study of the diagnostic value of plasma neurofilament light

Nicholas J. Ashton et al.

Nature Communications (2021)

Article Clinical Neurology

Motor neuron disease beginning with frontotemporal dementia: clinical features and progression

Marta Gromicho et al.

Summary: The study found that MND patients with FTD-onset have distinctive clinical features, including older age, predominant UMN phenotype, and progression to bulbar involvement after a median of 12 months. The main factor impacting functional decline and survival is the onset of bulbar dysfunction.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2021)

Review Neurosciences

Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Federico Verde et al.

Summary: ALS and FTD are currently incurable neurodegenerative diseases lacking specific neurochemical biomarkers, but NFL has shown considerable progress as a biomarker in both diseases, distinguishing them from mimic conditions and providing prognostic information.

FRONTIERS IN NEUROSCIENCE (2021)

Article Clinical Neurology

Evidence for GRN connecting multiple neurodegenerative diseases

Mike A. Nalls et al.

Summary: This study identified significant functional associations between increasing genetic risk in the GRN region and decreased expression of the gene in Parkinson's, Alzheimer's, and amyotrophic lateral sclerosis through expression quantitative trait locus analysis and genome-wide association studies. Additionally, colocalization analysis showed a connection between blood-based inflammatory biomarkers and GRN expression in the frontal cortex, suggesting that GRN expression mediates neuroinflammation function related to multiple neurodegenerative diseases. This analysis implies shared mechanisms for Parkinson's, Alzheimer's, and amyotrophic lateral sclerosis.

BRAIN COMMUNICATIONS (2021)

Article Clinical Neurology

Executive, language and fluency dysfunction are markers of localised TDP-43 cerebral pathology in non-demented ALS

Jenna M. Gregory et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)

Article Geriatrics & Gerontology

Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience

Leila Sellami et al.

NEUROBIOLOGY OF AGING (2020)

Article Clinical Neurology

In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET

Adam P. Mecca et al.

ALZHEIMERS & DEMENTIA (2020)

Review Neurosciences

The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Yevgeniya A. Abramzon et al.

FRONTIERS IN NEUROSCIENCE (2020)

Article Clinical Neurology

A novel p.N66T mutation in exon 3 of the SOD1 gene: report of two families of ALS patients with early cognitive impairment

Ilaria Martinelli et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2020)

Review Neurosciences

Circulating MicroRNAs as Diagnostic Biomarkers for Motor Neuron Disease

Lin Wang et al.

FRONTIERS IN NEUROSCIENCE (2020)

Article Neurosciences

Distinct molecular patterns of TDP-43 pathology in Alzheimer's disease: relationship with clinical phenotypes

Sandra O. Tome et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)

Article Clinical Neurology

Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis

Hannelore K. van der Burgh et al.

NEUROLOGY (2020)

Article Clinical Neurology

NEK1 and GRN mutations coexist in a sporadic Chinese Hui descent ALS patient

Kang Zhang et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2020)

Article Neurosciences

Quantitative patterns of motor cortex proteinopathy across ALS genotypes

Matthew Nolan et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)

Article Clinical Neurology

Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis

Oriol Dols-Icardo et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)

Article Medicine, Research & Experimental

Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia

Mercedes Prudencio et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Multidisciplinary Sciences

Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency

Jiasheng Zhang et al.

NATURE (2020)

Article Clinical Neurology

Early Referral to an ALS Center Reduces Several Months the Diagnostic Delay: A Multicenter-Based Study

Marina Martinez-Molina et al.

FRONTIERS IN NEUROLOGY (2020)

Article Clinical Neurology

Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase

Patrick Oeckl et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Review Clinical Neurology

Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies

David R. Beers et al.

LANCET NEUROLOGY (2019)

Review Neurosciences

Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis

Archana Prasad et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)

Article Clinical Neurology

Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia

Rebekah M. Ahmed et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)

Article Clinical Neurology

Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS/FTD-associated genes

Karin Forsberg et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Review Clinical Neurology

Magnetic Resonance Spectroscopy in ALS

Sanjay Kalra

FRONTIERS IN NEUROLOGY (2019)

Letter Clinical Neurology

LATE to the PART-y

Keith A. Josephs et al.

BRAIN (2019)

Letter Clinical Neurology

Reply: Limbic-predominant age-related TDP-43 encephalopathy (LATE)

Julie A. Schneider et al.

BRAIN (2019)

Review Clinical Neurology

Imaging in amyotrophic lateral sclerosis: MRI and PET

Jan Kassubek et al.

CURRENT OPINION IN NEUROLOGY (2019)

Article Neurosciences

Patterned functional network disruption in amyotrophic lateral sclerosis

Stefan Dukic et al.

HUMAN BRAIN MAPPING (2019)

Editorial Material Clinical Neurology

Untangling neuroinflammation in amyotrophic lateral sclerosis

Alexander Guy Thompson et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Review Clinical Neurology

Neuroinflammation in frontotemporal dementia

Fiona Bright et al.

NATURE REVIEWS NEUROLOGY (2019)

Review Clinical Neurology

Inflammation in ALS/FTD pathogenesis

Madelyn E. McCauley et al.

ACTA NEUROPATHOLOGICA (2019)

Article Clinical Neurology

Neurons selectively targeted in frontotemporal dementia reveal early stage TDP-43 pathobiology

Alissa L. Nana et al.

ACTA NEUROPATHOLOGICA (2019)

Article Clinical Neurology

Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS

Takashi Kasai et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)

Article Clinical Neurology

Elevated YKL-40 and low sAPPβ: YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD

Daniel Alcolea et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Article Clinical Neurology

Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis

Federico Verde et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Article Biochemical Research Methods

Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid

Alberto Lleo et al.

MOLECULAR & CELLULAR PROTEOMICS (2019)

Letter Clinical Neurology

Does ALS-FUS without FUS mutation represent ALS-FET? Report of three cases

S. Borrego-Ecija et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2019)

Review Neurosciences

ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?

Rita Mejzini et al.

FRONTIERS IN NEUROSCIENCE (2019)

Article Clinical Neurology

APP-derived peptides reflect neurodegeneration in frontotemporal dementia

Ignacio Illan-Gala et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)

Article Clinical Neurology

Cortical microstructural changes along the Alzheimer's disease continuum

Victor Montal et al.

ALZHEIMERS & DEMENTIA (2018)

Article Clinical Neurology

Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis

Alexander G. Thompson et al.

ANNALS OF NEUROLOGY (2018)

Article Neurosciences

Synaptic dysfunction and altered excitability in C90RF72 ALS/FTD

Alexander Starr et al.

BRAIN RESEARCH (2018)

Article Geriatrics & Gerontology

Distinct Clinical Features and Outcomes in Motor Neuron Disease Associated with Behavioural Variant Frontotemporal Dementia

Elena Cortes-Vicente et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2018)

Review Clinical Neurology

Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses

Federica Agosta et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2018)

Review Neurosciences

Towards a TDP-43-Based Biomarker for ALS and FTLD

Emily Feneberg et al.

MOLECULAR NEUROBIOLOGY (2018)

Article Clinical Neurology

Identification of compound heterozygous variants in OPTN in an ALS-FTD patient from the CReATe consortium: a case report

Cyril Pottier et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2018)

Review Clinical Neurology

Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses

Federica Agosta et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2018)

Article Neuroimaging

Cortical markers of cognitive syndromes in amyotrophic lateral sclerosis

Monica Consonni et al.

NEUROIMAGE-CLINICAL (2018)

Article Clinical Neurology

Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers

Lieke H. H. Meeter et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)

Review Clinical Neurology

C9orf72-mediated ALS and FTD: multiple pathways to disease

Rubika Balendra et al.

NATURE REVIEWS NEUROLOGY (2018)

Article Clinical Neurology

Serum neurofilament light chain in behavioral variant frontotemporal dementia

Petra Steinacker et al.

NEUROLOGY (2018)

Article Clinical Neurology

ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS

Christopher Crockford et al.

NEUROLOGY (2018)

Article Clinical Neurology

Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup

Ione O. C. Woollacott et al.

ALZHEIMERS RESEARCH & THERAPY (2018)

Article Clinical Neurology

CSF sAPP beta, YKL-40, and NfL along the ALS-FTD spectrum

Ignacio Illan-Gala et al.

NEUROLOGY (2018)

Article Clinical Neurology

Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43

Alexandra M. Wennberg et al.

JAMA NEUROLOGY (2018)

Review Cell Biology

MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis

Claudia Ricci et al.

CELLS (2018)

Article Clinical Neurology

Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis

Christopher M. Henstridge et al.

ACTA NEUROPATHOLOGICA (2018)

Article Clinical Neurology

TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing

Kirsty E. McAleese et al.

BRAIN PATHOLOGY (2017)

Article Clinical Neurology

Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis

Matthew D. Cykowski et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2017)

Article Clinical Neurology

Cognitive Impairment in Progressive Supranuclear Palsy Is Associated With Tau Burden

Shunsuke Koga et al.

MOVEMENT DISORDERS (2017)

Article Neurosciences

[18F]FDG PET signal is driven by astroglial glutamate transport

Eduardo R. Zimmer et al.

NATURE NEUROSCIENCE (2017)

Review Clinical Neurology

A clinicopathological approach to the diagnosis of dementia

Fanny M. Elahi et al.

NATURE REVIEWS NEUROLOGY (2017)

Review Clinical Neurology

Imaging and fluid biomarkers in frontotemporal dementia

Lieke H. Meeter et al.

NATURE REVIEWS NEUROLOGY (2017)

Review Neurosciences

Not just amyloid: physiological functions of the amyloid precursor protein family

Ulrike C. Mueller et al.

NATURE REVIEWS NEUROSCIENCE (2017)

Article Clinical Neurology

CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration

Daniel Alcolea et al.

NEUROLOGY (2017)

Article Cell Biology

Neurofilaments and Neurofilament Proteins in Health and Disease

Aidong Yuan et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)

Review Clinical Neurology

Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria

Michael J. Strong et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2017)

Article Cell Biology

Omic and Systems Biology Approaches in Neurodegenerative Diseases Applying fluid biomarkers to Alzheimer's disease

Henrik Zetterberg

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2017)

Article Clinical Neurology

Reappraisal of TDP-43 pathology in FTLD-U subtypes

Ian R. Mackenzie et al.

ACTA NEUROPATHOLOGICA (2017)

Article Medicine, Research & Experimental

Poly-GP in cerebrospinal fluid links C9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD

Carina Lehmer et al.

EMBO MOLECULAR MEDICINE (2017)

Article Clinical Neurology

Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients

Petra Steinacker et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)

Article Clinical Neurology

18F-FDG-PET correlates of cognitive impairment in ALS

Antonio Canosa et al.

NEUROLOGY (2016)

Article Clinical Neurology

New ALS-Related Genes Expand the Spectrum Paradigm of Amyotrophic Lateral Sclerosis

Mario Sabatelli et al.

BRAIN PATHOLOGY (2016)

Article Neurosciences

Structural brain correlates of cognitive and behavioral impairment in MND

Federica Agosta et al.

HUMAN BRAIN MAPPING (2016)

Article Clinical Neurology

Widespread structural brain involvement in ALS is not limited to the C9orf72 repeat expansion

Henk-Jan Westeneng et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)

Letter Clinical Neurology

Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum

Carlo Wilke et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)

Article Clinical Neurology

Increased functional connectivity common to symptomatic amyotrophic lateral sclerosis and those at genetic risk

Ricarda A. L. Menke et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)

Review Medicine, General & Internal

The frontotemporal dementia-motor neuron disease continuum

James R. Burrell et al.

LANCET (2016)

Article Clinical Neurology

Amyotrophic lateral sclerosis: moving towards a new classification system

Ammar Al-Chalabi et al.

LANCET NEUROLOGY (2016)

Review Clinical Neurology

Pathophysiological and diagnostic implications of cortical dysfunction in ALS

Nimeshan Geevasinga et al.

NATURE REVIEWS NEUROLOGY (2016)

Article Geriatrics & Gerontology

Voxel-Wise Meta-Analysis of Gray Matter Changes in Amyotrophic Lateral Sclerosis

Dongchao Shen et al.

FRONTIERS IN AGING NEUROSCIENCE (2016)

Article Clinical Neurology

Plasma neurofilament light chain predicts progression in progressive supranuclear palsy

Julio C. Rojas et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)

Article Clinical Neurology

Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection

Stefan Teipel et al.

LANCET NEUROLOGY (2015)

Article Geriatrics & Gerontology

Functional overlap and divergence between ALS and bvFTD

Francesca Trojsi et al.

NEUROBIOLOGY OF AGING (2015)

Article Clinical Neurology

Frontotemporal Dysfunction and Dementia in Amyotrophic Lateral Sclerosis

Susan C. Woolley et al.

NEUROLOGIC CLINICS (2015)

Editorial Material Clinical Neurology

GENETICS OF FRONTOTEMPORAL DEMENTIA IN ASIA: ADVANCING KNOWLEDGE THROUGH COLLABORATION

Adeline Su Lyn Ng

NEUROLOGY (2015)

Article Clinical Neurology

Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort

Ilse Gijselinck et al.

NEUROLOGY (2015)

Editorial Material Medicine, General & Internal

Precision Medicine - Personalized, Problematic, and Promising

J. Larry Jameson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Virology

From nucleation to widespread propagation: A prion-like concept for ALS

Zuzanna Maniecka et al.

VIRUS RESEARCH (2015)

Review Clinical Neurology

Diffusion imaging changes in grey matter in Alzheimer's disease: a potential marker of early neurodegeneration

Philip S. J. Weston et al.

ALZHEIMERS RESEARCH & THERAPY (2015)

Article Clinical Neurology

Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): A cognitive tool for motor disorders

Elaine Niven et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2015)

Article Clinical Neurology

Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy

Anna Montuschi et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)

Review Clinical Neurology

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases

Alberto Lleo et al.

NATURE REVIEWS NEUROLOGY (2015)

Article Clinical Neurology

Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia

Barbara Borroni et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2015)

Article Clinical Neurology

CSF neurofilament light chain reflects corticospinal tract degeneration in ALS

Ricarda A. L. Menke et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)

Review Clinical Neurology

The neuropathology associated with repeat expansions in the C9ORF72 gene

Ian R. A. Mackenzie et al.

ACTA NEUROPATHOLOGICA (2014)

Article Clinical Neurology

Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD)

Johannes Brettschneider et al.

ACTA NEUROPATHOLOGICA (2014)

Article Clinical Neurology

TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord

Johannes Brettschneider et al.

ACTA NEUROPATHOLOGICA (2014)

Article Clinical Neurology

Cerebrospinal Fluid Neurofilament Concentration Reflects Disease Severity in Frontotemporal Degeneration

Carole S. Scherling et al.

ANNALS OF NEUROLOGY (2014)

Article Clinical Neurology

ALS-Plus syndrome: Non-pyramidal features in a large ALS cohort

Leo McCluskey et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)

Review Clinical Neurology

The phenotypic variability of amyotrophic lateral sclerosis

Bart Swinnen et al.

NATURE REVIEWS NEUROLOGY (2014)

Article Geriatrics & Gerontology

Resting state functional connectivity alterations in primary lateral sclerosis

Federica Agosta et al.

NEUROBIOLOGY OF AGING (2014)

Article Clinical Neurology

Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis

Marco Pagani et al.

NEUROLOGY (2014)

Review Clinical Neurology

Prevalence of mixed pathologies in the aging brain

Jasmin Rahimi et al.

ALZHEIMERS RESEARCH & THERAPY (2014)

Article Clinical Neurology

Screening for cognition and behaviour changes in ALS

Sharon Abrahams et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2014)

Article Clinical Neurology

Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)

Sabrina Paganoni et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2014)

Article Clinical Neurology

Phosphorylated Tau as a Candidate Biomarker for Amyotrophic Lateral Sclerosis

Murray Grossman et al.

JAMA NEUROLOGY (2014)

Article Clinical Neurology

TREM2 Variant p.R47H as a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis

Janet Cady et al.

JAMA NEUROLOGY (2014)

Article Clinical Neurology

Apolipoprotein. E polymorphisms in frontotemporal lobar degeneration: A meta-analysis

Elisa Rubino et al.

ALZHEIMERS & DEMENTIA (2013)

Article Clinical Neurology

Stages of pTDP-43 Pathology in Amyotrophic Lateral Sclerosis

Johannes Brettschneider et al.

ANNALS OF NEUROLOGY (2013)

Article Geriatrics & Gerontology

Distinguishing Subtypes in Primary Progressive Aphasia: Application of the Sydney Language Battery

Sharon Savage et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2013)

Article Clinical Neurology

Basal ganglia involvement in amyotrophic lateral sclerosis

Peter Bede et al.

NEUROLOGY (2013)

Article Clinical Neurology

Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP

William T. Hu et al.

NEUROLOGY (2013)

Article Neurosciences

Altered cortical communication in amyotrophic lateral sclerosis

Stefanie Blain-Moraes et al.

NEUROSCIENCE LETTERS (2013)

Article Multidisciplinary Sciences

RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia

Tao Zu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Cell Biology

Prion-like Properties of Pathological TDP-43 Aggregates from Diseased Brains

Takashi Nonaka et al.

CELL REPORTS (2013)

Article Psychiatry

Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease

R. Perneczky et al.

TRANSLATIONAL PSYCHIATRY (2013)

Review Clinical Neurology

The genetics and neuropathology of amyotrophic lateral sclerosis

Ammar Al-Chalabi et al.

ACTA NEUROPATHOLOGICA (2012)

Article Clinical Neurology

Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis

Johannes Brettschneider et al.

ACTA NEUROPATHOLOGICA (2012)

Article Clinical Neurology

Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum

Patricia Lillo et al.

AMYOTROPHIC LATERAL SCLEROSIS (2012)

Article Clinical Neurology

The ALS-FTD-Q A new screening tool for behavioral disturbances in ALS

Joost Raaphorst et al.

NEUROLOGY (2012)

Article Multidisciplinary Sciences

Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis

Philippe Corcia et al.

PLOS ONE (2012)

Article Medicine, Research & Experimental

Neurotoxicity of Amyloid β-Protein: Synaptic and Network Dysfunction

Lennart Mucke et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)

Letter Clinical Neurology

A harmonized classification system for FTLD-TDP pathology

Ian R. A. Mackenzie et al.

ACTA NEUROPATHOLOGICA (2011)

Article Clinical Neurology

Motor Neuron dysfunction in frontotemporal dementia

James R. Burrell et al.

BRAIN (2011)

Article Biochemistry & Molecular Biology

The Frontotemporal Syndromes of ALS. Clinicopathological Correlates

Michael Joseph Strong et al.

JOURNAL OF MOLECULAR NEUROSCIENCE (2011)

Article Biochemistry & Molecular Biology

Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS

Jeban Ganesalingam et al.

JOURNAL OF NEUROCHEMISTRY (2011)

Article Geriatrics & Gerontology

A novel pathway for amyloid precursor protein processing

Erik Portelius et al.

NEUROBIOLOGY OF AGING (2011)

Review Clinical Neurology

Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Present and the Future

Roberta Ghidoni et al.

NEURODEGENERATIVE DISEASES (2011)

Review Clinical Neurology

Classification of primary progressive aphasia and its variants

M. L. Gorno-Tempini et al.

NEUROLOGY (2011)

Article Psychology, Clinical

Deficits in Emotional and Social Cognition in Amyotrophic Lateral Sclerosis

Alessandra Girardi et al.

NEUROPSYCHOLOGY (2011)

Article Clinical Neurology

Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis

Timothy Pyra et al.

AMYOTROPHIC LATERAL SCLEROSIS (2010)

Article Clinical Neurology

Detecting frontotemporal dysfunction in ALS: Utility of the ALS Cognitive Behavioral Screen (ALS-CBS™)

Susan C. Woolley et al.

AMYOTROPHIC LATERAL SCLEROSIS (2010)

Article Cell Biology

Prion-like disorders: blurring the divide between transmissibility and infectivity

Mimi Cushman et al.

JOURNAL OF CELL SCIENCE (2010)

Article Immunology

In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases

Dafna Bonneh-Barkay et al.

JOURNAL OF NEUROINFLAMMATION (2010)

Article Neurosciences

Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS

Jane O. Johnson et al.

NEURON (2010)

Article Multidisciplinary Sciences

Novel Antibodies Reveal Inclusions Containing Non-Native SOD1 in Sporadic ALS Patients

Karin Forsberg et al.

PLOS ONE (2010)

Article Geriatrics & Gerontology

Mixed Brain Pathologies in Dementia: The BrainNet Europe Consortium Experience

Gabor G. Kovacs et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2008)

Article Clinical Neurology

Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases

Hanae Nakashima-Yasuda et al.

ACTA NEUROPATHOLOGICA (2007)

Article Biochemistry & Molecular Biology

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Tetsuaki Arai et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Clinical Neurology

Cerebral degeneration predicts survival in amyotrophic lateral sclerosis

S. Kalra et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)

Article Biochemistry & Molecular Biology

Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration

Jennifer Gass et al.

HUMAN MOLECULAR GENETICS (2006)

Article Multidisciplinary Sciences

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Manuela Neumann et al.

SCIENCE (2006)

Article Clinical Neurology

Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations

Mark S. Forman et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)

Article Biochemistry & Molecular Biology

Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease

IL Goldknopf et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Clinical Neurology

Increased intrathecal inflammatory activity in frontotemporal dementia:: pathophysiological implications

M Sjögren et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)

Article Clinical Neurology

In vivo detection of microglial activation in frontotemporal dementia

A Cagnin et al.

ANNALS OF NEUROLOGY (2004)

Review Neurosciences

Looking into the functional architecture of the brain with diffusion MRI

D Le Bihan

NATURE REVIEWS NEUROSCIENCE (2003)

Article Clinical Neurology

Are amyotrophic lateral sclerosis patients cognitively normal?

C Lomen-Hoerth et al.

NEUROLOGY (2003)

Article Clinical Neurology

El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis

BR Brooks et al.

AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2000)

Article Behavioral Sciences

Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS)

S Abrahams et al.

NEUROPSYCHOLOGIA (2000)